Finally you hit the nail on the head. I think to bet on Indian market is not a good option.
Focusing on US, Europe, Japan, HK etc, is top priority. It would not be a good idea to tackle a secondary market via offering a low price.
Just a friendly reminder, MSB, even FDA approval were received next month, I'd bet they would be struggling to survive in a long run, due to constantly burning substantial cash. They were meant to make hefty cash flow from Japan market...
PNV, needs to focus on sales, easy to expand 5 times production capacity by 2025 via investing $25m, still has a good chance to succeed, imo.
Good luck all.
All imo.
PNV - Chart, page-16779
-
- There are more pages in this discussion • 2,452 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
0.020(0.78%) |
Mkt cap ! $1.780B | |||
| Open | High | Low | Value | Volume |
| $2.61 | $2.63 | $2.56 | $2.465M | 952.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10700 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 24502 | 5 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |